Jacob Asset Management Of New York LLC Harrow Health, Inc. Transaction History
Jacob Asset Management Of New York LLC
- $70.6 Million
- Q3 2023
A detailed history of Jacob Asset Management Of New York LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Jacob Asset Management Of New York LLC holds 91,779 shares of HROW stock, worth $2.71 Million. This represents 1.87% of its overall portfolio holdings.
Number of Shares
91,779
Previous 85,164
7.77%
Holding current value
$2.71 Million
Previous $1.62 Million
18.69%
% of portfolio
1.87%
Previous 1.84%
Shares
12 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$117 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$63.5 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$55.8 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$55.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$28.3 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $800M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...